| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |